Total Valuation
Molecular Partners AG has a market cap or net worth of $156.16M. The enterprise value is $41.99M.
Market Cap$156.16M
Enterprise Value$41.99M
Share Statistics
Molecular Partners AG has 40,374,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding40,374,640
Owned by Insiders―
Owned by Institutions0.03%
Financial Efficiency
Molecular Partners AG’s return on equity (ROE) is -0.77 and return on invested capital (ROIC) is -60.07%.
Return on Equity (ROE)-0.77
Return on Assets (ROA)-0.60
Return on Invested Capital (ROIC)-60.07%
Return on Capital Employed (ROCE)-0.61
Revenue Per Employee0.00
Profits Per Employee-390.20K
Employee Count158
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Molecular Partners AG is ―. Molecular Partners AG’s PEG ratio is -0.54.
PE Ratio―
PS Ratio0.00
PB Ratio1.57
Price to Fair Value1.57
Price to FCF-2.51
Price to Operating Cash Flow-2.45
PEG Ratio-0.54
Income Statement
In the last 12 months, Molecular Partners AG had revenue of 0.00 and earned -61.65M in profits. Earnings per share was -1.65.
Revenue0.00
Gross Profit-2.15M
Operating Income-55.44M
Pretax Income-61.65M
Net Income-61.65M
EBITDA-53.26M
Earnings Per Share (EPS)-1.65
Cash Flow
In the last 12 months, operating cash flow was -47.95M and capital expenditures -266.00K, giving a free cash flow of -48.22M billion.
Operating Cash Flow-47.95M
Free Cash Flow-48.22M
Free Cash Flow per Share-1.19
Dividends & Yields
Molecular Partners AG pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.43
52-Week Price Change-14.69%
50-Day Moving Average3.34
200-Day Moving Average3.21
Relative Strength Index (RSI)34.99
Average Volume (3m)52.00
Important Dates
Molecular Partners AG upcoming earnings date is Aug 25, 2026, TBA (Confirmed).
Last Earnings DateMar 12, 2026
Next Earnings DateAug 25, 2026
Ex-Dividend Date―
Financial Position
Molecular Partners AG as a current ratio of 8.79, with Debt / Equity ratio of 4.89%
Current Ratio8.79
Quick Ratio8.79
Debt to Market Cap0.00
Net Debt to EBITDA1.48
Interest Coverage Ratio-15.84
Taxes
In the past 12 months, Molecular Partners AG has paid 2.00K in taxes.
Income Tax2.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Molecular Partners AG EV to EBITDA ratio is -0.89, with an EV/FCF ratio of -0.94.
EV to Sales0.00
EV to EBITDA-0.89
EV to Free Cash Flow-0.94
EV to Operating Cash Flow-0.96
Balance Sheet
Molecular Partners AG has $78.77M in cash and marketable securities with $3.34M in debt, giving a net cash position of $75.42M billion.
Cash & Marketable Securities$78.77M
Total Debt$3.34M
Net Cash$75.42M
Net Cash Per Share$1.87
Tangible Book Value Per Share$2.16
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Molecular Partners AG is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-100.00%
EPS Growth Forecast0.03%